Published in Virus Genes on August 01, 2005
A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol (2007) 9.90
suPAR: the molecular crystal ball. Dis Markers (2009) 2.55
Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses. Gastroenterology (2007) 1.88
Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization. Proc Natl Acad Sci U S A (2008) 1.82
CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect (2007) 1.55
Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection. J Infect Dis (2008) 1.50
Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology. Clin Chem (2006) 1.40
Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children. Eur J Pediatr (2010) 1.40
Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One (2008) 1.39
A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis (Edinb) (2011) 1.34
Monomer dimer dynamics and distribution of GPI-anchored uPAR are determined by cell surface protein assemblies. J Cell Biol (2007) 1.30
IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay. BMC Res Notes (2009) 1.29
Finding coevolving amino acid residues using row and column weighting of mutual information and multi-dimensional amino acid representation. Algorithms Mol Biol (2007) 1.25
miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts. Nucleic Acids Res (2013) 1.21
A community study of clinical traits and risk factors for human metapneumovirus and respiratory syncytial virus infection during the first year of life. Eur J Pediatr (2008) 1.21
Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score. Int J Cardiol (2012) 1.20
Correlates for disease progression and prognosis during concurrent HIV/TB infection. Int J Infect Dis (2007) 1.18
Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy. J Med Virol (2008) 1.18
Soluble urokinase receptor is elevated in cerebrospinal fluid from patients with purulent meningitis and is associated with fatal outcome. Scand J Infect Dis (2004) 1.15
MaxAlign: maximizing usable data in an alignment. BMC Bioinformatics (2007) 1.13
Epstein-Barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor. J Virol (2005) 1.10
Human metapneumovirus and respiratory syncytial virus in hospitalized danish children with acute respiratory tract infection. Scand J Infect Dis (2004) 1.06
Clathrin and LRP-1-independent constitutive endocytosis and recycling of uPAR. PLoS One (2008) 1.06
Primary pneumocystis infection in infants hospitalized with acute respiratory tract infection. Emerg Infect Dis (2007) 1.05
Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study. Crit Care (2012) 1.05
suPAR - a future risk marker in bacteremia. J Intern Med (2011) 1.05
Investigating signs of recent evolution in the pool of proviral HIV type 1 DNA during years of successful HAART. AIDS Res Hum Retroviruses (2007) 1.04
CRP and suPAR are differently related to anthropometry and subclinical organ damage. Int J Cardiol (2012) 1.04
High mortality risk among individuals assumed to be TB-negative can be predicted using a simple test. Trop Med Int Health (2009) 1.03
Common TNF-alpha, IL-1 beta, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis. BMC Infect Dis (2007) 1.01
InterMap3D: predicting and visualizing co-evolving protein residues. Bioinformatics (2009) 1.01
Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B. PLoS One (2013) 1.00
Immunogenicity of a 2-dose priming and booster vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine. Pediatr Infect Dis J (2009) 0.99
Assessment of simple risk markers for early mortality among HIV-infected patients in Guinea-Bissau: a cohort study. BMJ Open (2012) 0.97
A simple method to quantitate IP-10 in dried blood and plasma spots. PLoS One (2012) 0.95
Urine suPAR levels compared with plasma suPAR levels as predictors of post-consultation mortality risk among individuals assumed to be TB-negative: a prospective cohort study. Inflammation (2010) 0.95
Characterisation of rotavirus strains among hospitalised and non-hospitalised children in Guinea-Bissau, 2002 A high frequency of mixed infections with serotype G8. J Clin Virol (2005) 0.95
Increased plasma soluble uPAR level is a risk marker of respiratory cancer in initially cancer-free individuals. Cancer Epidemiol Biomarkers Prev (2011) 0.94
Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper. Eur Respir J (2013) 0.93
Incubation of whole blood at 39°C augments gamma interferon (IFN-γ)-induced protein 10 and IFN-γ responses to Mycobacterium tuberculosis antigens. Clin Vaccine Immunol (2011) 0.93
Plasma soluble urokinase plasminogen activator receptor in children with urinary tract infection. Biomark Insights (2011) 0.92
Risk factors for onset of asthma: a 12-year prospective follow-up study. Chest (2006) 0.91
Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study. PLoS One (2013) 0.91
Arkadia regulates tumor metastasis by modulation of the TGF-β pathway. Cancer Res (2013) 0.91
Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention. Am J Cardiol (2012) 0.90
Diagnostic value of soluble CD163 serum levels in patients suspected of meningitis: comparison with CRP and procalcitonin. Scand J Infect Dis (2007) 0.90
NT-proBNP, C-reactive protein and soluble uPAR in a bi-ethnic male population: the SAfrEIC study. PLoS One (2013) 0.89
TTV viral load as a marker for immune reconstitution after initiation of HAART in HIV-infected patients. HIV Clin Trials (2002) 0.88
Genetics of the ceramide/sphingosine-1-phosphate rheostat in blood pressure regulation and hypertension. BMC Genet (2011) 0.88
Cell-associated HIV DNA measured early during infection has prognostic value independent of serum HIV RNA measured concomitantly. Scand J Infect Dis (2002) 0.88
Immunological predictors of survival in HIV type 2-infected rural villagers in Guinea-Bissau. AIDS Res Hum Retroviruses (2005) 0.86
Soluble urokinase plasminogen activator receptor for risk prediction in patients admitted with acute chest pain. Clin Chem (2013) 0.86
TBscore II: refining and validating a simple clinical score for treatment monitoring of patients with pulmonary tuberculosis. Scand J Infect Dis (2013) 0.84
Evidence for vertical inheritance and loss of the leukotoxin operon in genus Mannheimia. J Mol Evol (2007) 0.84
Soluble urokinase plasminogen activator receptor (suPAR) is associated with metabolic changes in HIV-1-infected Africans: a prospective study. Inflammation (2012) 0.83
Inflammation in HIV-infected patients: impact of HIV, lifestyle, body composition, and demography - a cross sectional cohort study. PLoS One (2012) 0.83
Identification of a novel Mannheimia granulomatis lineage from lesions in roe deer (Capreolus capreolus). J Wildl Dis (2007) 0.83
suPAR associates to glucose metabolic aberration during glucose stimulation in HIV-infected patients on HAART. J Infect (2008) 0.82
Bayesian prediction of bacterial growth temperature range based on genome sequences. BMC Genomics (2012) 0.82
Outcome in adulthood of asymptomatic airway hyperresponsiveness to histamine and exercise-induced bronchospasm in childhood. Ann Allergy Asthma Immunol (2005) 0.81
Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids. Carcinogenesis (2013) 0.80
Inflammatory markers in the second trimester prior to clinical onset of preeclampsia, intrauterine growth restriction, and spontaneous preterm birth. Inflammation (2013) 0.80
Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus. J Infect Dis (2003) 0.80
The prognostic value of the suPARnostic ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphisms. BMC Infect Dis (2007) 0.80
Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine. Eur J Pediatr (2005) 0.80
Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency. Clin Immunol (2009) 0.80
Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment. PLoS One (2012) 0.79
Factors associated with asthma in young Danish adults. Ann Allergy Asthma Immunol (2002) 0.79
Genetic evolution of HIV in patients remaining on a stable HAART regimen despite insufficient viral suppression. Scand J Infect Dis (2005) 0.79
Chronic mucus hypersecretion: a marker of asthma in young adults? Respir Med (2005) 0.79
Exploring soluble urokinase plasminogen activator receptor and its relationship with arterial stiffness in a bi-ethnic population: the SAfrEIC-study. Thromb Res (2011) 0.79
Hepatitis B virus DNA in saliva from children with chronic hepatitis B infection: implications for saliva as a potential mode of horizontal transmission. Pediatr Infect Dis J (2010) 0.78
Assessment of in situ adipose tissue inflammation by microdialysis. Clin Physiol Funct Imaging (2014) 0.78
Hepatitis B surface antigen quantity positively correlates with plasma levels of microRNAs differentially expressed in immunological phases of chronic hepatitis B in children. PLoS One (2013) 0.78
Prospective study of the burden of rotavirus gastroenteritis in Danish children and their families. Eur J Pediatr (2011) 0.77
Horizontal transmission of hepatitis B virus--why discuss when we can vaccinate? J Infect Dis (2012) 0.77
Soluble urokinase plasminogen activator receptor, C-reactive protein and triglyceride are associated with heart rate variability in non-diabetic Danes. Eur J Clin Invest (2013) 0.76
No influence of GB virus C on disease progression in a Danish cohort of HIV-infected men. AIDS Res Hum Retroviruses (2006) 0.76
Low Prevalence of Parvovirus 4 in HIV-infected Children in Denmark. Pediatr Infect Dis J (2015) 0.76
Respiratory symptoms in greenlanders living in Greenland and Denmark: a population-based study. Ann Allergy Asthma Immunol (2004) 0.76
Evolution of the leukotoxin promoter in genus Mannheimia. BMC Evol Biol (2009) 0.75
Presence and significance of TT virus in Danish patients on maintenance hemodialysis. Scand J Urol Nephrol (2003) 0.75
Pattern recognition receptor responses in children with chronic hepatitis B virus infection. J Clin Virol (2012) 0.75
Children Hospitalized With Varicella in Denmark: Sensitivity of the National Patient Register. Pediatr Infect Dis J (2017) 0.75
Nanomechanical recognition of prognostic biomarker suPAR with DVD-ROM optical technology. Nanotechnology (2013) 0.75
[Treatment of bronchiolitis in children. A survey of a Cochrane review]. Ugeskr Laeger (2008) 0.75
Therapeutic Vaccine Against Primate Papillomavirus Infections of the Cervix. J Immunother (2017) 0.75